AC1115 TFA is a potent, selective antiviral drug and the active form of olgotrelvir. AC1115 TFA targets the Mpro of SARS-CoV-2 as well as the host lysosomal cysteine protease cathepsin L (CTSL), exhibiting high antiviral activity.
Molecular Weight:
526.51
Purity:
99.15%
Formula:
C24H29F3N4O6
Target:
SARS-CoV|||Virus Protease|||Cysteine Protease
T202641L
* VAT and and shipping costs not included. Errors and price changes excepted